2019 Regulatory Presentation: The Interplay of Regulatory Policy and Control of Listeria Monocytogenes in Frozen Foods
This presentation was provided at the 2019 Regulatory Workshop. The presenter, Donna Garren, presented on Defining Ready-To-Eat Foods in the Absence of FDA Guidance, including RTE vs NRTE food recalls, Listeria Monocytogenes in frozen foods, and AFFI's strategy.
Membership Required
A valid ASTA membership is required to access this page. Please use the form below to log in with your ASTA member account.
Log in
Not a member yet? Click here to learn about joining ASTA today.
Related Resources
2015 Regulatory Presentation: FSMA Implementation and Compliance, FDA
This presentation was provided at the 2015 Regulatory Workshop in October. FDA presented the final rule for Preventive Controls for Human Food, including the PCHF, assurances regarding PCs, and food storage.
ASTA Ready-to-Eat FAQs
The microbial safety of “ready-to-eat” (RTE) foods is a hot topic that ASTA is hearing a lot about when it comes to implementation of the Food Safety Modernization Act (FSMA). The U.S. Food and Drug Administration (FDA) has not yet published guidance regarding classifying and processing RTE foods. In these “frequently asked questions” (FAQs), ASTA is sharing information on positions FDA could take on RTE based on the preambles to the FSMA final rules, talks that FDA officials have given, information published in the update to the spice draft risk profile, informal conversations with FDA officials, and other published FDA draft guidance. ASTA has produced these FAQs in order to help members understand FDA’s current thinking on RTE foods, but we note that we have not received input on this document from FDA.
